Simon Gill rejoined Needham & Company in January 2010, having previously been a senior healthcare banker at the firm. In the last 15 years Simon has completed over 200 transactions for life science companies. These include IPOs, Follow-on Offerings and Registered Direct Offerings, PIPEs, Private Placements, Convertible Debt, Royalty Financings, M&A Advisory, Shareholder Rights Plans […]

Mike Matson joined Needham & Company in 2013 covering Medical Technologies & Diagnostics. Prior to joining Needham, Mike spent nine years covering the Medical Supplies and Devices industry for Mizuho Securities and Wells Fargo Securities. He previously worked in the medical device industry for Stryker’s Orthopaedics and Endoscopy divisions in marketing and product development. Mike […]

Serge Belanger joined Needham & Company in 2009, where he covers the Biotechnology sector. Prior to Needham, Serge worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors. Previously, Serge was part of Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where […]